COCP
COCP
NASDAQ · Pharmaceuticals

Cocrystal Pharma Inc

$1.38
-0.05 (-3.50%)
As of May 9, 2:22 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,923.2% upside
Low Target $19.61
Average Target $27.92
High Target $38.36
Current Price $1.38
Current
$1.38
Target
$27.92
$19.61 $27.92 avg $38.36
Scenario Analysis
Bear Case
$19.61
1,321.0%
Low target
Base Case
$27.92
+1,923.2%
Avg target
Bull Case
$38.36
+2,679.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.67
-48.3% from high
52-Week Low
$0.86
+60.7% from low
Target vs 52W High
$27.92
+945.7% vs high
Next Earnings Report
May 18, 2026
7d
until earnings
EPS Est: $-0.15
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%